![Dennis Purcell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Purcell
Vorsitzender bei
SOLVONIS THERAPEUTICS PLC
Vermögen: 134 334 $ am 31.05.2026
Profil
Mr. Dennis J.
Purcell is a Non-Executive Chairman at Solvonis Therapeutics Plc, a Director at Rosetta Capital Ltd., an Independent Director and Advisor at Bioscience Managers Pty Ltd., a Founder & Senior Advisor at Aisling Capital LLC, an Advisor at The New York City Investment Fund Manager, Inc. and a Chief Operating Officer & Director at Summus Global, Inc. He is on the Board of Directors at ViralClear Pharmaceuticals, Inc., Bioscience Managers Pty Ltd., Summus Global, Inc., Real Endpoints LLC and Ichnos Glenmark Innovation, Inc. Mr. Purcell was previously employed as a Special Advisor to the CEO by Awakn Life Sciences Corp., an Independent Director by Paratek Pharmaceuticals, Inc. /Old/, a Managing Director by Chase H&Q, a Member by Harvard Medical School, a Managing Director by PaineWebber, Inc., and an Executive Chairman by Poliwogg Holdings, Inc. He also served on the board at Embera NeuroTherapeutics, Inc., Aton Pharma, Inc., Biotechnology Innovation Organization, Bridge Pharmaceuticals, Inc., Cengent Therapeutics, Inc., Dynova Laboratories, Inc., New York Biotechnology Association, Inc., The Irvington Institute for Immunological Research, Valentis, Inc. and Xanodyne Pharmaceuticals, Inc. He received his undergraduate degree from the University of Delaware and an MBA from Harvard University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.05.2025 | 39’861’638 ( 0.59% ) | 134 334 $ | 31.05.2026 |
Aktive Positionen von Dennis Purcell
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLVONIS THERAPEUTICS PLC | Vorsitzender | 26.09.2024 |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Gründer | 01.01.1998 |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Berater | - |
Real Endpoints LLC
 Real Endpoints LLC Data Processing ServicesTechnology Services Provides information and analytics services | Direktor/Vorstandsmitglied | - |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Direktor/Vorstandsmitglied | 01.01.2003 |
Summus Global, Inc.
 Summus Global, Inc. Internet Software/ServicesTechnology Services Operates as virtual healthcare platform | Geschäftsführer | - |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Direktor/Vorstandsmitglied | - |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Direktor/Vorstandsmitglied | 28.05.2020 |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Private Equity Investor | 30.10.2017 |
Ehemalige bekannte Positionen von Dennis Purcell
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Dennis Purcell
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
27
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 27 |
|---|---|
Valentis, Inc.
 Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
Cengent Therapeutics, Inc.
 Cengent Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches & develops pharmaceutical drugs | Commercial Services |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Bridge Pharmaceuticals, Inc.
 Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services to the pharmaceutical industry | Commercial Services |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for smoking cessation, cocaine dependence and other addictions | Health Technology |
Dynova Laboratories, Inc.
 Dynova Laboratories, Inc. Food RetailRetail Trade Develops and markets natural healthcare products and supplements | Retail Trade |
Poliwogg Holdings, Inc.
 Poliwogg Holdings, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical therapeutics for cancer and other diseases | Health Technology |
Chase H&Q
 Chase H&Q Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Finance |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Finance |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
The Irvington Institute for Immunological Research
 The Irvington Institute for Immunological Research Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Real Endpoints LLC
Real Endpoints LLC Data Processing ServicesTechnology Services Provides information and analytics services | Technology Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Summus Global, Inc.
Summus Global, Inc. Internet Software/ServicesTechnology Services Operates as virtual healthcare platform | Technology Services |
Graft Polymer (UK) Plc
 Graft Polymer (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Develops polymer modification technologies | Producer Manufacturing |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Health Technology |
Awakn Life Sciences Corp.
 Awakn Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides psychedelic assisted psychotherapy solutions | Health Services |
